Developing a new algorithm for first and second trimester preeclampsia screening in twin pregnancies

References

• Redman CW, Sargent IL. Latest advances in understanding preeclampsia. Science 2005;308(5728):1592–4.
   PubMed Web of Science ®Google Scholar
• Cetin I, Huppertz B, Burton G, et al. Pregenesys pre-eclampsia markers consensus meeting: What do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 2011;32:S4–S16.
   PubMed Web of Science ®Google Scholar
• Sibai BM, Hauth J, Caritis S, et al. Hypertensive disorders in twin versus singleton gestations. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 2000;182:938–42.
   Google Scholar
• Bdolah Y, Lam C, Rajakumar A, et al.Twin pregnancy and the risk of preeclampsia: Bigger placenta or relative ischemia. Am J Obstet Gynecol 2008;198:428.e1–6.
   PubMed Web of Science ®Google Scholar
• The European Perinatal Health Report 2010. http://www.europeristat.com.
   Google Scholar
• Barker DJ. Fetal nutrition and cardiovascular disease in later life. Br Med Bull 1997;53:96–108.
   PubMed Web of Science ®Google Scholar
• Irgens HU, Reisaeter L, Irgens LM, Lie RT. Long term mortality of mothers and fathers after pre-eclampsia: Population based cohort study. Br Med J 2001;323:1213–7.
   PubMed Web of Science ®Google Scholar
• Shmueli A, Meiri H, Gonen G. Economic assessment of screening for pre-eclampsia. Prenat Diagn 2012;32:29–38.
   PubMed Web of Science ®Google Scholar
• Dolea C, AbouZahr C. Global Burden of Hypertensive Disorders of Pregnancy in the Year 2000. Geneva: World Health Organization (WHO); 2003. http://www.who.int/healthinfo/bod_hypertensivedisordersofpregnancy.pdf.
   Google Scholar
• WHO. Recommendations for Prevention and Treatment of Preeclampsia and Eclampsia. Geneva. http://whqlibdoc.who.int/publications/2011/9789241548335_eng.pdf.
   Google Scholar
• Hypertension in pregnancy: The management of hypertensive disorders during pregnancy. National Collaborating Centre for Women and Children Health (UK). National Institute for Clinical Excellence. Guidelines CG107. Published August 2019; Last updated January . 2011http://www.nice.org.uk/guidance/cg107/chapter/1-guidance.
   Google Scholar
• Akolekar R, Syngelaki A, Sarquis R, et al. Prediction of early, intermediate and late pre-eclampsia from maternal factors, biophysical and biochemical markers at 11–13 weeks. Prenat Diagn 2011;31:66–74. Erratum in: Prenat Diagn 2011;31:832.
   Google Scholar
• Smith GC, Stenhouse EJ, Crossley JA, et al. Early pregnancy levels of pregnancy-associated plasma protein a and the risk of intrauterine growth restriction, premature birth, preeclampsia, and stillbirth. J Clin Endocrin Metab 2002;87:1762–7.
   PubMed Web of Science ®Google Scholar
• Crispi F, Domínguez C, Llurba E, et al. Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol 2006;195:201–7.
   PubMed Web of Science ®Google Scholar
• Martin AM, Bindra R, Curcio P, et al. Screening for pre-eclampsia and fetal growth restriction by uterine artery Doppler at 11–14 weeks of gestation. Ultrasound Obstet Gynecol 2001;18:583–6.
   PubMed Web of Science ®Google Scholar
• Poon LCY, Karagiannis G, Leal A, et al. Hypertensive disorders in pregnancy: Screening by uterine artery Doppler imaging and blood pressure at 11–13 weeks. Ultrasound Obstet Gynecol 2009;34:497–502.
   PubMed Web of Science ®Google Scholar
• Wright D, Syngelaki A, Akolekar R, et al. Competing risks model in screening for preeclampsia by maternal characteristics and medical history. Am J Obstet Gynecol 2015;213:62.
   PubMed Web of Science ®Google Scholar
• O’Gorman N, Wright D, Syngelaki A, et al. Competing risks model in screening for preeclampsia by maternal factors and biomarkers at 11–13 weeks gestation. Am J Obstet Gynecol 2016;214:103.e1–e103.e12.
   Google Scholar
• Gabbay-Benziv R, Oliveira N, Baschat AA. Optimal first trimester preeclampsia prediction: A comparison of multimarker algorithm, risk profiles and their sequential application. Prenat Diagn 2016;36:34–9.
   PubMed Web of Science ®Google Scholar
• Klein K, Mailath-Pokorny M, Elhenicky M, et al. Mean, lowest, and highest pulsatility index of the uterine artery and adverse pregnancy outcome in twin pregnancies. Am J Obstet Gynecol 2011;205:549.e1–7
   PubMed Web of Science ®Google Scholar
• Svirsky R, Yagel S, Ben-Ami I, et al. First trimester markers of pre-eclampsia in twins: mean arterial pressure and uterine artery Doppler pulsatility index. Prenat Diagn 2014;34:956–60.
   PubMed Web of Science ®Google Scholar
• Svirsky R, Levinsohn-Tavor O, Feldman N, et al. Early pregnancy maternal serum markers of pre-eclampsia in twins. Ultrasound Obstet Gynecol 2016;47:560–4.
   PubMed Web of Science ®Google Scholar
• Svirsky R, Meiri H, Herzog A, et al. First trimester maternal serum placental protein 13 levels in singleton versus twin pregnancies with and without severe pre-eclampsia. J Perinat Med 2013;41:561–6.
   PubMed Web of Science ®Google Scholar
• Than NG, Balogh A, Romero R, et al. Placental Protein 13 (PP13) – A placental immunoregulatory galectin protecting pregnancy. Front Immunol 2014;5:348.
   PubMed Web of Science ®Google Scholar
• Huppertz B, Meiri H, Gizurarson S, et al. Placental protein 13 (PP13): A new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Hum Reprod Update 2013;19:391–405.
   PubMed Web of Science ®Google Scholar
• Hadlock FP, Shah YP, Kanon DJ, Lindsey JV. Fetal crown-rump length: Reevaluation of relation to menstrual age (5–18 weeks) with high-resolution real-time US. Radiology 1992;182:501–5.
   PubMed Web of Science ®Google Scholar
• Gonen R, Shahar R, Grimpel YI, et al. Placental protein 13 as an early marker for pre-eclampsia: A prospective longitudinal study. BJOG 2008:115;1465–72.
   PubMed Web of Science ®Google Scholar
• Khalil A, Cowans NJ, Spencer K, et al. First-trimester markers for the prediction of pre-eclampsia in women with a-priori high risk. Ultrasound Obstet Gynecol 2010;35:671–9.
   PubMed Web of Science ®Google Scholar
• Than NG, Pick E, Bellyei S, et al. Functional analyses of placental protein 13/galectin-13. Eur J Biochem 2004;271:1065–78.
   PubMedGoogle Scholar
• Than NG, Romero R, Goodman M, et al. A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death. Proc Natl Acad Sci USA 2009;106:9731–6.
   PubMed Web of Science ®Google Scholar
• Koster MP, Wortelboer EJ, Stoutenbeek P, et al. Distributions of current and new first-trimester Down syndrome screening markers in twin pregnancies. Prenat Diagn 2010;30:413–7.
   PubMed Web of Science ®Google Scholar
• Lindheimer MD, Taler SJ, Cunningham FG. American Society of Hypertension position paper: Hypertension in pregnancy. Clin Hypertens (Greenwich) 2009;11:214–25.
   PubMed Web of Science ®Google Scholar
• Sibai BM. Publications Committee, Society for Maternal-Fetal Medicine. Evaluation and management of severe pre-eclampsia. Am J Obstet Gynecol 2011;205:191–8.
   PubMedGoogle Scholar
• Crosley EJ, Dunk CE, Beristain AG, Christians JK. IGFBP-4 and -5 are expressed in first-trimester villi and differentially regulate the migration of HTR-8/SVneo cells. Reprod Biol Endocrinol 2014;12:123–7.
   PubMed Web of Science ®Google Scholar
• Gizurarson S, Sigurdardottir ER, Meiri H, et al. Placental protein 13 administration to pregnant rats lowers blood pressure and augments fetal growth and venous remodeling. Fetal Diagn Ther 2016;39:56–63.
   PubMed Web of Science ®Google Scholar
• Shu C, Liu Z, Cui L, et al. Protein profiling of preeclampsia placental tissues. PLoS One 2014;9(11):e112890.
   Google Scholar
• Verlohren S, Melchiorre K, Khalil A, Thilaganathan B. Uterine artery Doppler, birth weight and timing of onset of preeclampsia: Providing insights into the dual etiology of late-onset pre-eclampsia. Ultrasound Obstet Gynecol 2014;44:293–8.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Sharma R, Thilaganathan B. Cardiovascular implications in preeclampsia: an overview. Circulation 2014;130:703–14.
   PubMed Web of Science ®Google Scholar
• Melchiorre K, Sutherland G, Sharma R, et al. Mid-gestational maternal cardiovascular profile in preterm and term preeclampsia: A prospective study. Br J Obstet Gyneacol 2013;120:496–504.
   Google Scholar
• Osol G, Bernstein I. Preeclampsia and maternal cardiovascular disease: Consequence or predisposition? J Vasc Res 2014;51:290–304.
   PubMed Web of Science ®Google Scholar
• Wright D, Gallo DM, Gil Pugliese S, Cadssanova C, Nicolaides KH. Contingency screening for preterm pre-eclampsia. Ultrasound Obstet Gynecol 2016;47;554–9.
   PubMed Web of Science ®Google Scholar
• Bujold E, Roberge S, Lacasse Y, et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: A meta-analysis. Obstet Gynecol 2010;116:402–14.
   PubMed Web of Science ®Google Scholar
• Park F, Russo K, Williams P, et al. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening. Ultrasound Obstet Gynecol 2015;46:419–23.
   PubMed Web of Science ®Google Scholar
• Roberg S, Demers S, Nicolaides KH, et al. Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: A meta analysis. Ultrasound Obstet Gynecol 2016;47:548–53.
   Google Scholar
• Hofmeyr GJ, Lawrie TA, Atallah AN, et al. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database Syst Rev 2014;6:CD001059.
   Google Scholar
• Syngelaki A, Nicolaides KN. Metformin in obese non-diabetic pregnant women (MOP study). The 14th World Congress of Fetal medicine, Crete. 2015. http://www.ukctg.nihr.ac.uk/trials/trial-details/trial-details?trialNumber=NCT01273584.
   Google Scholar
• Dastjerdi MV, Hosseini S, Bayani L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci 2012;17:632–36.
   PubMed Web of Science ®Google Scholar